Recent Updates
Recently added Catalysts
DYN

Dyne Therapeutics Announces Pricing of $168 Million Public Offering

Wednesday, January 20, 2021 1 min read
Key Takeaway: Dyne Therapeutics Announces Pricing of $168 Million Public Offering

Full Press Release Details

Dyne Therapeutics Announces Pricing of $168 Million Public Offering.
Tags: DYN Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jan 20, 2021